Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory Study (TSAP)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
VitrOmics BV
Information provided by:
VU University Medical Center
ClinicalTrials.gov Identifier:
NCT01190241
First received: August 26, 2010
Last updated: June 2, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)